JAKARTA - PT Industri Jamu dan Pharmacy Sido Muncul Tbk (SIDO) will boost performance in the rest of this year. One of them, by encouraging the growth in sales volume of herbal products.

"We are also expanding export country coverage to 15 percent in 3-5 years, as well as sustainable and sustainable efforts in efficiency," said Director of Sido Muncul, Budiyanto at the Public Expose Live 2024, Wednesday, August 28.

As of June 2024, SIDO pocketed a net profit of IDR 608.49 billion, an increase of 35.79 percent from the same period last year which amounted to IDR 448.10 billion.

In line with that, SIDO sales also rose 14.67 percent to Rp1.89 trillion from the previous Rp1.65 trillion.

In detail, sales of herbal herbal medicine and supplements were recorded at IDR 1.11 trillion, food and beverage products recorded sales of IDR 716.70 billion and sales of pharmaceutical products amounting to IDR 66.19 billion.

In terms of expenditure, the company's cost of goods sold increased to Rp792.88 billion, from the previous Rp776.25 billion.

SIDO's sales and marketing expenses were recorded at IDR 259.60 billion, as well as general and administrative expenses of IDR 92.09 billion.

SIDO's total asset value was recorded at IDR 3.82 trillion, down 1.73 percent from the December 2023 position of IDR 3.89 trillion. The company's liabilities were recorded at IDR 353.82 billion and equity was IDR 3.46 trillion.

"The company will continue to improve performance in a better direction to meet investor and stakeholder expectations, and consistently implement good corporate governance," said Budiyanto.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)